Colorectal Cancer Screening in China: Early Detection Window Exceeds 10 Years
For patients researching colorectal cancer screening abroad, the time window for catching the disease early can be the single most important factor in survival. A feature on China’s national broadcaster CCTV-13 highlights that colorectal cancer has a detection window exceeding 10 years, and when caught early, the cure rate can reach 90%. This news, reported by the Second Affiliated Hospital of Zhejiang University School of Medicine (Zhejiang University School of Medicine Second Affiliated Hospital), underscores why proactive screening is a priority in Chinese oncology centers.
Colorectal Cancer Screening: A 10-Year Window of Opportunity
According to the CCTV-13 report featured by Zhejiang University School of Medicine Second Affiliated Hospital, colorectal cancer is unique among major cancers because of its exceptionally long preclinical window. The development from precancerous polyps to invasive carcinoma typically takes more than a decade. This extended period provides a critical opportunity for intervention. When detected during this phase, the early diagnosis rate can reach as high as 90%, dramatically improving patient outcomes. The report emphasizes that regular screening—primarily colonoscopy—is the most effective tool for identifying and removing polyps before they become malignant.
Why Early Detection Matters for Colorectal Cancer
Colorectal cancer is one of the most common malignancies worldwide, but it is also one of the most preventable. The high early diagnosis rate cited in the report is directly tied to the ability to intervene during the polyp stage. A colonoscopy allows physicians to visualize the entire colon and remove suspicious growths immediately, effectively preventing cancer from developing. For patients who already have early-stage cancer, minimally invasive surgical techniques and targeted therapies offer excellent prognoses. The 90% early diagnosis rate reflects the combined power of public health awareness, accessible screening programs, and advanced endoscopic technology available in leading Chinese hospitals.
Zhejiang University School of Medicine Second Affiliated Hospital’s Role in Oncology
Zhejiang University School of Medicine Second Affiliated Hospital, one of China’s oldest and most respected medical institutions, operates a dedicated oncology center that integrates screening, diagnosis, and treatment. The hospital’s tumor center is equipped with advanced imaging and endoscopic equipment, supporting the kind of early detection highlighted in the CCTV-13 segment. Their multidisciplinary teams include gastroenterologists, oncologists, and colorectal surgeons who collaborate on personalized treatment plans. For international patients, this means access to a system where screening protocols align with the goal of catching colorectal cancer within that critical 10-year window.
The hospital’s international medical department provides services tailored to foreign patients, including appointment coordination, language support, and assistance with medical records. While the report focuses on domestic public health messaging, the infrastructure behind it—high-volume endoscopy units, experienced specialists, and integrated care pathways—is equally available to patients traveling from abroad. The emphasis on early detection is not just a public health slogan; it is embedded in clinical practice. More information about colorectal cancer treatment options can be found through the National Cancer Institute’s colorectal cancer screening overview.
The CCTV-13 segment also touches on risk factors such as diet, family history, and age, noting that screening should begin earlier for individuals with elevated risk. Chinese guidelines increasingly recommend starting screening at age 45 for average-risk individuals, a shift that reflects the growing understanding of early-onset colorectal cancer trends. The World Health Organization’s fact sheet on colorectal cancer provides additional context on global screening recommendations and disease burden.
While the specific technology of colonoscopy is well-established globally, this report reflects a broader reality: Chinese oncology centers are increasingly prioritizing early detection programs and public education to shift the curve toward curable-stage diagnoses. For international patients, this means access to screening protocols and endoscopic expertise that align with the goal of finding colorectal cancer early—when the cure rate is highest.
What This Means for Patients
For anyone considering colorectal cancer screening or treatment abroad, the message is clear: the window for early detection is long, but it requires action. The 90% early diagnosis rate cited in this report is achievable when screening is done properly and on time. Patients looking for affordable surgery in China or exploring options for getting medical care in China as a foreigner should know that leading hospitals offer colonoscopy and related procedures at a fraction of the cost found in many Western countries, without sacrificing quality. The key is to choose a hospital with a dedicated international patient program and a strong track record in gastroenterology and oncology. Early detection saves lives, and the infrastructure to support that goal is already in place at major Chinese medical centers.
Source: 浙大二院